Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001683168-25-007264
Filing Date
2025-09-26
Accepted
2025-09-26 17:00:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT sonoma_424b5.htm 424B5 302279
2 GRAPHIC image_001.jpg GRAPHIC 6302
3 GRAPHIC image_003.jpg GRAPHIC 6740
4 GRAPHIC image_005.jpg GRAPHIC 6302
  Complete submission text file 0001683168-25-007264.txt   330493
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-275311 | Film No.: 251351261
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)